Main publications and posters' presentations

Publications

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
JNCI J Natl Cancer Inst - Volume98, Issue4 - bPp. 262-272
Authors: Christos Sotiriou et al.

 

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Breast Cancer Research 2008, 10:R65doi:10.1186/bcr2124
Authors: Pratyaksha Wirapati et al

 

Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade
Journal of Clinical Oncology, Vol 25, No 10 (April 1), 2007: pp. 1239-1246
Authors: Sherene Loi et al.

 

Understanding the Molecular Basis of Histologic Grade
Pathobiology 2008;75:104-111 (DOI: 10.1159/000123848)
Authors: M. Ignatiadis et al.

 

Genomic Grade Index Is Associated With Response to Chemotherapy in Patients With Breast Cancer
Journal of Clinical Oncology,July 1, 2009 vol. 27 no. 19 3185-3191
Authors: Cornelia Liedtke et al.

 

High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy
Cancer, 2011 Feb 1;117(3):472-9. doi: 10.1002/cncr.25626. Epub 2010 Sep 27.
Authors: Naoi Y et al.

Posters

GGI_in_Lobulars_ASCO2011-Poster_discussion.pdf

Use of genomic grade index to improve tumor grading of invasive lobular breast carcinoma / Otto Metzger Filho (Institut Jules Bordet, Université Libre de Bruxelles, Belgium) et al.

MQ_Feasibility_ASCO2011-Poster.pdf

Genomic grade: Feasibility in routine practice and influence on treatment decision in early breast cancer / Otto Metzger Filho (Institut Jules Bordet, Université Libre de Bruxelles, Belgium) et al.

Ki67_SABCS_2010.pdf

Genomic Grade Index (GGI): tumor grading performance and prognostic value compared to Ki67 and Mitotic Index in early invasive breast cancer – a reference centre experience / F Reyal (Department of Surgery, Institut Curie, Paris, France) et al.

Medico-eco_SABCS_2010.pdf

Influence of the Genomic Grade Index on adjuvant treatment strategy in Elston-Ellis Grade 2,Estrogen Receptor positive, HER2 negative, Node negative, Small size breast carcinomas / F Reyal (Department of Surgery, Institut Curie, Paris, France) et al.

NPI_SABCS_2010.pdf

Combining Genomic Grade and NPI refines risk group classification / Hélène Peyro-Saint-Paul (IPSOGEN SA, Marseille, France) et al.

GGI_ASCO_2009.pdf

The genomic grade index (GGI) has higher prognostic value than centrally-measured Ki-67 IHC and mitotic index in early breast cancer patients / F. Bertucci(Institut Paoli-Calmettes, Marseille,France) et al.

© IPSOGEN  2012